Monolith Series
Medical device
The Monolith is at the core of the NanoTemper range of MicroScale Thermophoresis analyzers. NanoTemper's unique MST technology that detects binding affinities of molecules has revolutionized analytics in rapid drug development. The second generation of the Monolith offers testing in close-to-native conditions and comes with more comprehensive testing capabilities and an enhanced interface. Monolith exceeds competitors in ease of use and the technical finesse that allows analysis with tiny amounts of sample material. The bold design manifests both NanoTemper's technological excellence and dynamic approach to the laboratory environment.
Date of Launch
2020
Development Time
13 - 24 months
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Other target groups: Basic research and drug development